Osteoporosis: screening, prevention, and management
- PMID: 25841602
- DOI: 10.1016/j.mcna.2015.01.010
Osteoporosis: screening, prevention, and management
Abstract
Osteoporosis is characterized by low bone mineral density (BMD) and abnormal bone architecture. Common fracture sites are vertebrae, proximal femur, and distal forearm. Osteoporosis is underdiagnosed and undertreated. All women 65 and older should be screened. Consider screening younger postmenopausal women with elevated risk. Osteoporosis is diagnosed based on T score or a fragility fracture. Women with osteoporosis or who have a 10-year risk of any major fracture of 20% or hip fracture of 3% should be evaluated for causes of low bone density and treated with an osteoporosis-specific medication, lifestyle interventions, and calcium and vitamin D intake.
Keywords: Fragility fractures; Management; Osteopenia; Osteoporosis; Prevention; Screening.
Published by Elsevier Inc.
Similar articles
-
Who is at risk of receiving inadequate care for osteoporosis following fragility fractures? A retrospective study.Isr Med Assoc J. 2013 Oct;15(10):634-8. Isr Med Assoc J. 2013. PMID: 24266091
-
Preventing osteoporotic fractures in older people.Practitioner. 2011 Jan;255(1736):19-22, 2-3. Practitioner. 2011. PMID: 21370710
-
Hip fractures, preceding distal radius fractures and screening for osteoporosis: should we be screening earlier? A minimum 10-year retrospective cohort study at a single centre.Osteoporos Int. 2016 Jan;27(1):361-6. doi: 10.1007/s00198-015-3375-8. Epub 2015 Oct 28. Osteoporos Int. 2016. PMID: 26510846
-
Diagnosis, screening, prevention, and treatment of osteoporosis.Mayo Clin Proc. 2006 May;81(5):662-72. doi: 10.4065/81.5.662. Mayo Clin Proc. 2006. PMID: 16706264 Review.
-
Osteoporosis prevention, diagnosis, and therapy.NIH Consens Statement. 2000 Mar 27-29;17(1):1-45. NIH Consens Statement. 2000. PMID: 11525451 Review.
Cited by
-
NRF2 in age-related musculoskeletal diseases: Role and treatment prospects.Genes Dis. 2023 Nov 27;11(6):101180. doi: 10.1016/j.gendis.2023.101180. eCollection 2024 Nov. Genes Dis. 2023. PMID: 39281838 Free PMC article. Review.
-
Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis.Biomolecules. 2024 Aug 8;14(8):970. doi: 10.3390/biom14080970. Biomolecules. 2024. PMID: 39199358 Free PMC article. Review.
-
SIRT3: A Potential Target of Different Types of Osteoporosis.Cell Biochem Biophys. 2024 Jun;82(2):489-500. doi: 10.1007/s12013-024-01254-4. Epub 2024 Mar 21. Cell Biochem Biophys. 2024. PMID: 38512537 Review.
-
Identification of mitophagy-related biomarkers in human osteoporosis based on a machine learning model.Front Physiol. 2024 Jan 8;14:1289976. doi: 10.3389/fphys.2023.1289976. eCollection 2023. Front Physiol. 2024. PMID: 38260098 Free PMC article.
-
miR-155-5p/Bmal1 Modulates the Senescence and Osteogenic Differentiation of Mouse BMSCs through the Hippo Signaling Pathway.Stem Cell Rev Rep. 2024 Feb;20(2):554-567. doi: 10.1007/s12015-023-10666-3. Epub 2023 Dec 27. Stem Cell Rev Rep. 2024. PMID: 38150082 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
